Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer

S

SCRI Development Innovations

Status

Completed

Conditions

Unknown Primary Cancer

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00876408
SCRI OUTCOMES 08

Details and patient eligibility

About

This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay results are consistent with clinical features and useful for planning initial therapy or changing therapy.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients with RT-PCR testing completed since commercialization of the RT-PCR assay in 2007.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems